Target intelligence / Profile preview

Parasympathetic fibers innervating cranial blood vessels

Molecular classification
Other
01

Overview

Parasympathetic fibers innervating cranial blood vessels constitute the efferent arm of the trigemino-parasympathetic reflex, primarily originating from the sphenopalatine ganglion (SPG). These fibers provide dense innervation to the dural and cerebral vasculature, where they release potent vasodilatory mediators such as vasoactive intestinal peptide (VIP), acetylcholine, and nitric oxide. In pathological states like migraine and cluster headache, overactivity of these fibers leads to significant cranial vasodilation and plasma protein extravasation, contributing to the severe pain and autonomic symptoms (e.g., lacrimation and rhinorrhea) characteristic of these disorders. Medical intervention typically focuses on desensitizing this pathway through neuromodulation of the SPG, local anesthetic blocks, or pharmacological agents like botulinum toxin that inhibit neurotransmitter release. Recent drug development has also targeted specific receptors for the neuropeptides released by these fibers, such as VIP receptor antagonists, to provide more localized and effective relief for trigeminal autonomic cephalgias.

Other names
Cranial parasympathetic outflowSphenopalatine ganglion efferentsTrigemino-parasympathetic pathwayCranial autonomic fibers
02

Mechanism of action

Therapeutic strategies involve the inhibition of neurotransmitter release (e.g., acetylcholine), the blockade of ganglionic transmission via local anesthetics, or the antagonism of effector neuropeptides like vasoactive intestinal peptide (VIP) to prevent cranial vasodilation and neurogenic inflammation.

03

Biological functions

VasodilationGlandular secretionNeurogenic inflammationNociceptive modulation
04

Disease associations

MigraineCluster headacheTrigeminal autonomic cephalgiasHemicrania continua
05

Safety considerations

Xerophthalmia (dry eyes)Xerostomia (dry mouth)Nasal congestion or drynessInvasive procedural risks (e.g., infection or nerve injury during SPG blocks)Potential for transient facial numbness
06

Interacting drugs

OnabotulinumtoxinA

4 more in the full profile.

07

Biomarkers

Vasoactive intestinal peptide (VIP) plasma levelsCranial blood flow (Laser Doppler)Lacrimation volume

Beyond the preview

Go deeper on Parasympathetic fibers innervating cranial blood vessels.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Parasympathetic fibers innervating cranial blood vessels.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call